2024-03-28T23:04:55Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_076642AE6AC4
2024-03-23T01:48:51Z
serval:BIB_076642AE6AC4
Characterisation of multifocal breast cancer using the 70-gene signature in clinical low-risk patients enrolled in the EORTC 10041/BIG 03-04 MINDACT trial.
10.1016/j.ejca.2017.03.034
000402872000011
28477490
Aalders
K.C.
author
Kuijer
A.
author
Straver
M.E.
author
Slaets
L.
author
Litiere
S.
author
Viale
G.
author
Van't Veer
L.J.
author
Glas
A.M.
author
Delorenzi
M.
author
van Dalen
T.
author
Tryfonidis
K.
author
Piccart
M.J.
author
Cardoso
F.
author
Rutgers
E.J.
author
TRANSBIG Consortium and the MINDACT Investigators
contributor
article
2017-07
European journal of cancer
1879-0852
0959-8049
journal
79
98-105
Adolescent
Adult
Age Distribution
Aged
Antineoplastic Agents/therapeutic use
Breast Neoplasms/genetics
Breast Neoplasms/pathology
Breast Neoplasms/therapy
Disease-Free Survival
Female
Gene Expression Profiling/methods
Gene Expression Regulation, Neoplastic/genetics
Genes, Neoplasm/genetics
Genome, Human
Humans
Lymphatic Metastasis
Mastectomy/statistics & numerical data
Middle Aged
Receptor, ErbB-2/metabolism
Receptors, Estrogen/metabolism
Receptors, Progesterone/metabolism
Transcriptome/genetics
Young Adult
70-Gene signature
Breast cancer
MammaPrint(®)
Metastasis
Multifocal
Prognosis
eng
60_published
peer-reviewed
Publication types: Journal Article ; Randomized Controlled Trial
Publication Status: ppublish